DE69921096D1 - Auf bibapcitide gegründete pharmaceutische zusammensetzungen für bildgebung und behandlung von thromben - Google Patents

Auf bibapcitide gegründete pharmaceutische zusammensetzungen für bildgebung und behandlung von thromben

Info

Publication number
DE69921096D1
DE69921096D1 DE1999621096 DE69921096T DE69921096D1 DE 69921096 D1 DE69921096 D1 DE 69921096D1 DE 1999621096 DE1999621096 DE 1999621096 DE 69921096 T DE69921096 T DE 69921096T DE 69921096 D1 DE69921096 D1 DE 69921096D1
Authority
DE
Germany
Prior art keywords
thrombens
bibapcitide
treating
improving
pharmaceutical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE1999621096
Other languages
English (en)
Other versions
DE69921096T2 (de
Inventor
T Dean
John Lister-James
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CIS Bio International SA
Original Assignee
Diatide Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9802681A external-priority patent/GB9802681D0/en
Application filed by Diatide Inc filed Critical Diatide Inc
Publication of DE69921096D1 publication Critical patent/DE69921096D1/de
Application granted granted Critical
Publication of DE69921096T2 publication Critical patent/DE69921096T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/08Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE69921096T 1998-02-06 1999-02-05 Auf bibapcitide gegründete pharmaceutische zusammensetzungen für bildgebung und behandlung von thromben Expired - Fee Related DE69921096T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US09/020,086 US6028056A (en) 1998-02-06 1998-02-06 Pharmaceutical compositions for imaging and treating thrombi
US20086 1998-02-06
GB9802681 1998-02-06
GB9802681A GB9802681D0 (en) 1998-02-06 1998-02-06 Pharmaceutical compoations for imaging and treating thrombi
PCT/US1999/002583 WO1999039747A1 (en) 1998-02-06 1999-02-05 Bipapcitide-based pharmaceutical compositions for imaging and treating thrombi

Publications (2)

Publication Number Publication Date
DE69921096D1 true DE69921096D1 (de) 2004-11-18
DE69921096T2 DE69921096T2 (de) 2006-02-02

Family

ID=26313082

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69921096T Expired - Fee Related DE69921096T2 (de) 1998-02-06 1999-02-05 Auf bibapcitide gegründete pharmaceutische zusammensetzungen für bildgebung und behandlung von thromben

Country Status (26)

Country Link
US (1) US6028056A (de)
EP (1) EP1053027B1 (de)
JP (1) JP2003532617A (de)
KR (1) KR100452390B1 (de)
CN (1) CN1103606C (de)
AR (1) AR018546A1 (de)
AT (1) ATE279214T1 (de)
AU (1) AU761778B2 (de)
BR (1) BR9908352A (de)
CA (1) CA2319544C (de)
DE (1) DE69921096T2 (de)
DK (1) DK1053027T3 (de)
EA (1) EA005406B1 (de)
ES (1) ES2229681T3 (de)
HK (1) HK1032198A1 (de)
HU (1) HUP0100887A3 (de)
IL (1) IL137076A (de)
NO (1) NO20003881D0 (de)
NZ (1) NZ505085A (de)
PE (1) PE20000250A1 (de)
PL (1) PL342253A1 (de)
PT (1) PT1053027E (de)
SI (1) SI1053027T1 (de)
SK (1) SK284463B6 (de)
TW (1) TWI246425B (de)
WO (1) WO1999039747A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2744802T3 (pl) 2011-08-17 2017-07-31 Piramal Imaging Sa Związki do wiązania do glikoproteiny IIB/IIIA specyficznej wobec płytek i ich zastosowanie do obrazowania zakrzepów
WO2014124943A1 (en) 2013-02-12 2014-08-21 Bayer Pharma Aktiengesellschaft Metal chelate compounds for binding to the platelet specific glycoprotein iib/iiia

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830856A (en) * 1991-02-08 1998-11-03 Diatide, Inc. Radiolabeled compounds for thrombus imaging
US5645815A (en) * 1991-02-08 1997-07-08 Diatide, Inc. Radiolabled compounds for thrombus imaging
US5508020A (en) * 1992-06-05 1996-04-16 Diatech, Inc. Technetium-99M labeled peptides for imaging
JP2941057B2 (ja) * 1992-05-21 1999-08-25 ダイアテク,インコーポレイテッド 血栓造影用のテクネチウム‐99m標識ペプチド

Also Published As

Publication number Publication date
HUP0100887A2 (hu) 2001-06-28
EA005406B1 (ru) 2005-02-24
JP2003532617A (ja) 2003-11-05
EA200000820A1 (ru) 2001-02-26
PE20000250A1 (es) 2000-06-02
ATE279214T1 (de) 2004-10-15
PT1053027E (pt) 2005-01-31
NO20003881L (no) 2000-07-28
KR100452390B1 (ko) 2004-10-08
WO1999039747A1 (en) 1999-08-12
SK11392000A3 (sk) 2001-03-12
CA2319544A1 (en) 1999-08-12
BR9908352A (pt) 2000-11-28
DK1053027T3 (da) 2005-01-17
AU2660499A (en) 1999-08-23
ES2229681T3 (es) 2005-04-16
CN1103606C (zh) 2003-03-26
HK1032198A1 (en) 2001-07-13
SI1053027T1 (en) 2005-04-30
HUP0100887A3 (en) 2003-08-28
CA2319544C (en) 2006-07-04
SK284463B6 (sk) 2005-04-01
EP1053027A1 (de) 2000-11-22
AU761778B2 (en) 2003-06-12
NZ505085A (en) 2002-10-25
AR018546A1 (es) 2001-11-28
IL137076A (en) 2004-08-31
KR20010040676A (ko) 2001-05-15
IL137076A0 (en) 2001-06-14
US6028056A (en) 2000-02-22
DE69921096T2 (de) 2006-02-02
NO20003881D0 (no) 2000-07-28
EP1053027B1 (de) 2004-10-13
TWI246425B (en) 2006-01-01
CN1290179A (zh) 2001-04-04
PL342253A1 (en) 2001-06-04

Similar Documents

Publication Publication Date Title
ATE477270T1 (de) Verfahren und zusammensetzungen zur prävention und behandlung von anämie
ATE318138T1 (de) Pharmazeutisches mittel zur behandlung von diabetes
DE69925306D1 (de) Behandlung von kohlenwasserstoffgas
ATE179610T1 (de) Zusammensetzung zur behandlung ovarieller östrogenabhängiger krankheiten
ATE247987T1 (de) Behandlung zur beseitigung von gerüchen
ATE300597T1 (de) Behandlung von geweben
DE60023128D1 (de) Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen
DE60108080D1 (de) Aminopyrazolderivate zur behandlung von übergewicht und anderen gesundheitsstörungen
ATE308997T1 (de) Mittel zur behandlung von erkrankungen der speiseröhre
DE69510920D1 (de) Galaktomannan-produkte und diese enthaltende zusammensetzungen
DE69806579D1 (de) Anlage zur behandlung von nahrungsmitteln
DE69834693D1 (de) Zusammensetzung zur behandlung von elastischen polyurethanfasern und die damit behandelten fasern
DE69836008D1 (de) Zusammensetzung und behandlungsmittel
ATA11989A (de) Mittel zur vorbeugung gegen und behandlung von parodontopathien
DE10082139T1 (de) Zusammensetzung zur Behandlung von Reibungspaaren
DE69729817D1 (de) Behandlung von Aldehyd-fixierten Geweben
ATE263777T1 (de) Zusammensetzungen zur behandlung von entzündungsreaktionen
DE69918842D1 (de) Desinfektionszusammensetzungen und verfahren
DE69519577D1 (de) Prednisolonmetasulfobenzoatzusammensetzung zur behandlung von entzündungserkrankung des darmes
DE69900168D1 (de) Zusammensetzung zur Behandlung von Papier und damit behandeltes Papier
DE69721756D1 (de) Paroxetine zur behandlung von depression
DE69900339D1 (de) Mittel und Verfahren zur Behandlung von Kunstfasern
DE69905214D1 (de) Mittel zur Behandlung der Osteoporose
DE60001255D1 (de) Zusammensetzung zur Behandlung von Polyesterfaser
DE69913380D1 (de) Zusammensetzung zur behandlung von periodontalen erkrankungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: CIS BIO INTERNATIONAL, GIF-SUR-YVETTE, FR

8339 Ceased/non-payment of the annual fee